MK-1708

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1708, covering 2024-12-18 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) [Phase 1]